- Cash and equivalents stood at $124.5M as of Sept 30, 2026, including $50.1M gross proceeds from private placement.
- Cash runway expected to fund planned operations through the end of 2028.
- Regulatory clearance received in UK/EU to expand Phase 1/2 ASCEND trial of CMP-002.
Signal #151837 · SEC 8-K
$CAMP SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $CAMP filing catalyst
Why did $CAMP trigger an AI stock catalyst alert?
$CAMP triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Camp4 Therapeutics Reports Q3 2026 Results, Cash Runway Extended to End of 2028. Key points: - Cash and equivalents stood at $124.5M as of Sept 30, 2026, including $50.1M gross proceeds from private placement. - Cash runway expected to fund planned operations through the end of 2028. - Regulatory clearance received in UK/EU to expand Phase 1/2 ASCEND trial of CMP-002.
How did $CAMP stock react after the SEC filing?
After the SEC 8-K for $CAMP, observed market reaction: T0 price $3.72. Past moves do not guarantee future results.
Where can I get real-time $CAMP SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $CAMP via Telegram and the VIP Web Terminal from €10/month.